Design and synthesis of hapten to induce phospholipase A2-like catalytic antibody

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 3, 1997, Pages 251-254

  Isomura, Shigeki ^a   Haruna, Mitsumasa ^a   Kazuo, Ito ^a  

^a MEIJO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATALYTIC ANTIBODY; HAPTEN; PHOSPHOLIPASE A2;

ARTICLE; COLORIMETRY; DRUG DESIGN; DRUG SYNTHESIS; ENZYME INHIBITION; HYDROLYSIS; IN VITRO STUDY; PHOSPHOLIPID METABOLISM; REACTION ANALYSIS; X RAY ANALYSIS;

EID: 0031552084     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)00018-8     Document Type: Article

References (30)

1. 1. Tramontano, A.; Janda, K. D.; Lerner, R. A. Science. 1986, 234, 1566.
2. 2. Pollack, S. J.; Jacobs, J. W.; Schultz, P. G. Science, 1986, 234, 1570.
3. 3. Stewart, J. D.; Benkovic, S. J. Nature, 1995, 375, 388. and references cited therein.
4. 4. (a) Miyashita, H.; Karaki, Y.; Kikuchi, M.; Fujii, I. Proc. Natl. Acad. Sci. USA 1993, 90, 5337.
5. (b) Campbell, D. A.; Gong, B.; Kochersperger, L. M.; Yonkovich, S.; Gallop, M. A.; Schultz, P. G. J. Am. Chem. Soc. 1994, 116, 2165.
6. 5. (a) Kudo, I.; Inoue, K. Seikagaku, 1992, 64, 1330.
7. (b) Arita. H, Nakano, T.; and Hayasaki, K. Prog. Lipid Res., 1989, 28, 273.
8. (c) Mahadevappa, V. G.; B. Holub, B. Biochem. Biophys. Res. Commun., 1986, 134, 1327.
9. (d) Kaya, H.; Patton, G. M.; Hong, S. L. J. Biol. Chem., 1989, 264, 4972.
10. (e) Bicknell, R.; Valee, B. L. Proc. Natl. Acad. Sci. U.S.A., 1989, 86, 1573.
11. 6. (a) Elamrani, K.; Blume, A. Biochemistry, 1982, 21, 521.
12. (b) Prado, A.; Partearroyo, A.; Mencia, M.; Goni, F. M.; Barbera-Guillem, E. FEBS Lett., 1989, 259, 149.
13. (c) Cheronomordik, L. V.; Vogel, S.; Leikina, E.; Zimmerberg, J. FEBS Lett., 1993, 318, 71.
14. (d) Yeagle, P. L.; Smith, F. T.; Young, J. E.; Flanagan, T. D. Biochemistry, 1994, 33, 1820. and references cited therein.
15. 7. (a) Tamura, M.; Kochi, J. Synthesis, 1971, 303.
16. (b) C. Descoins, C.; Henrick, C. A. Tetrahedron Lett., 1972, 2999.
17. 8. Dickert Jr., J. J.; Rowe, C. N. U. S. Patent, 3,798,162 1974.
18. 9. Diastereomers 7a and 7a′ (1/1) from 5a and 7b and 7b′ (1/1) from 5b were used for further reaction without purification.
19. 10. Heymans, F.; Michel, E.; Borrel, M.; Wichrowski, B.; Godfroid, J.; Convert, O.; Coeffier, E.; Tence, M.; and Benveniste, J. Biochim. Biophys. Acta, 1981, 666, 230. and references cited therein.
20. +.
21. 12. (a) Yuan, W.; Gelb, M. H. J. Am. Chem. Soc., 1988, 110, 2665.
22. (b) Jain, M. K.; Yuan, W.; Gelb, M. H. Biochemistry, 1989, 28, 4135.
23. (c) Lin, H. -K.; Gelb, M. H. J. Am. Chem. Soc., 1993, 115, 3932.
24. +.
25. 14. (a) Shimizu, S.; Tani, Y.; Yamada, H.; Tabata, M.; Murachi, T. Anal. Biochem., 1980, 107, 193.
26. (b) Harris, R. J. J. Pediatr., 1974, 84, 578. This assay kit was purchased from Boehringer Mannheim. The assay solution containing 3.95mM lecithin, 1.93mM Triton X-100, 1mM sodium deoxycholate and 2mM calcium chloride in 62.5mM of Tris-HCl buffer at pH 8.0 was used.
27. 15. Yuan, W.; Berman, R. J.; Gelb, M. H. J. Am. Chem. Soc., 1987, 109, 3932.
28. 16. White, S. P.; Scott, D. L.; Otwinowski, Z.; Gelb, M. H.; Sigler, P. B. Science, 1990, 250, 1560.
29. 17 (a) Scott, D. L.; White, S. P.; Otwinowski, Z.; Yuan, W.; Gelb, M. H.; Sigler, P. B. Science, 1990, 250, 1541.
30. (b) Scott, D. L.; Otwinowski, Z.; Gelb, M. H.; Sigler, P. B. Science, 1990, 250, 1563.